A research team from the University of Geneva in Switzerland has developed a new artificial intelligence system that can accurately assess the risk of tumor metastasis and recurrence by analyzing complex gene expression profiles, offering the potential to enhance personalized diagnosis and treatment for patients with various types of cancer.
